Community Health Systems Inc: Form 10-Q for the period ended Jun 30, 2024
Filed with the SEC on Jul 25, 2024 and accepted by EDGAR at Jul 25, 2024, 16:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-04-01 to 2024-06-30 | $3.14bn | us-gaap:Revenues |
| Revenue | 6 months2024-01-01 to 2024-06-30 | $6.28bn | us-gaap:Revenues |
| Cost of revenue | 3 months2024-04-01 to 2024-06-30 | $483.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2024-01-01 to 2024-06-30 | $969.0m | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months2024-04-01 to 2024-06-30 | $238.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-01-01 to 2024-06-30 | $468.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-04-01 to 2024-06-30 | $24.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-01-01 to 2024-06-30 | $52.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-04-01 to 2024-06-30 | −$13.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-01-01 to 2024-06-30 | −$55.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-04-01 to 2024-06-30 | −$0.10 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-01-01 to 2024-06-30 | −$0.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-04-01 to 2024-06-30 | −$0.10 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-01-01 to 2024-06-30 | −$0.42 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-04-01 to 2024-06-30 | 132,344,504 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-01-01 to 2024-06-30 | 131,808,274 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-01-01 to 2024-06-30 | $197.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-01-01 to 2024-06-30 | $181.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-06-30 | $39.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-06-30 | $3.20bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-06-30 | $14.41bn | us-gaap:Assets |
| Current liabilities | At period end2024-06-30 | $2.17bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-06-30 | $15.29bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-06-30 | $11.50bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-06-30 | −$1.44bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-086552. Last ingested by Listed: Oct 29, 2026, 18:46 ET. Listed shows no prices and gives no investment advice.